Voya Investment Management LLC Design Therapeutics, Inc. Transaction History

Voya Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$4.99 - $7.64 $4,630 - $7,089	928 Added 7.05%	14,090 $88,000
Q4 2022 Feb 14, 2023	SELL	$7.86 - $17.2 $110,708 - $242,262	-14,085 Reduced 51.69%	13,162 $135,000
Q3 2022 Mar 03, 2023	BUY	$14.09 - $25.57 $198,457 - $360,153	14,085 Added 107.01%	27,247 $455,000
Q3 2022 Nov 14, 2022	BUY	$14.09 - $25.57 $206,770 - $375,239	14,675 Added 116.73%	27,247 $456,000
Q2 2022 Aug 15, 2022	BUY	$9.91 - $17.33 $124,588 - $217,872	12,572 New	12,572 $176,000

102

31M

2.3K

16.5K

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $347M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.